Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Induction Chemotherapy + Concurrent Chemoradiotherapy in Nasopharyngeal Cancer
NCT00997906Phase 3Unknown
- Sponsor
- National Cancer Centre Singapore
- Start
- Sep 2009
- Primary completion
- Dec 2017
- Modality
- DNA Intercalators/Alkylators, Cytokines & Interferons, Fc-Fusion Proteins
- Countries
- 1
01
Overview
A Phase 3 trial of gemcitabine, carboplatin, Paclitaxel Micelles for Injection in nasopharyngeal carcinoma (NPC), sponsored by National Cancer Centre Singapore. Status: unknown.
02
Drugs
gemcitabinecarboplatinPaclitaxel Micelles for Injection
03
Conditions
nasopharyngeal carcinoma (NPC)
Beyond the preview
Go deeper on NCT00997906.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00997906.